These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

150 related items for PubMed ID: 21502797

  • 1. Early hypertension and prolonged mineralocorticoid therapy discontinuation in a child with salt-wasting 21-hydroxylase deficiency.
    Wasniewska M, Valenzise M, Aversa T, Mirabelli S, De Luca F, De Luca FL, Lombardo F.
    J Endocrinol Invest; 2011 Feb; 34(2):159-61. PubMed ID: 21502797
    [No Abstract] [Full Text] [Related]

  • 2. Effect of carbenoxolone on the plasma renin activity and hypothalamic-pituitary-adrenal axis in congenital adrenal hyperplasia due to 21-hydroxylase deficiency.
    Irony I, Cutler GB.
    Clin Endocrinol (Oxf); 1999 Sep; 51(3):285-91. PubMed ID: 10469007
    [Abstract] [Full Text] [Related]

  • 3. Requirement of mineralocorticoid in congenital adrenal hyperplasia due to 11 beta-hydroxylase deficiency.
    Hochberg Z, Benderly A, Kahana L, Zadik Z.
    J Clin Endocrinol Metab; 1986 Jul; 63(1):36-40. PubMed ID: 3011843
    [Abstract] [Full Text] [Related]

  • 4. Molecular testing in congenital adrenal hyperplasia due to 21α-hydroxylase deficiency in the era of newborn screening.
    Sarafoglou K, Lorentz CP, Otten N, Oetting WS, Grebe SK.
    Clin Genet; 2012 Jul; 82(1):64-70. PubMed ID: 21534945
    [Abstract] [Full Text] [Related]

  • 5. Vaginal bleeding and a giant ovarian cyst in an infant with 21-hydroxylase deficiency.
    Şahin NM, Bayramoğlu E, Çetinkaya S, Erdeve ŞŞ, Karaman A, Akdoğan MP, Aycan Z.
    J Pediatr Endocrinol Metab; 2018 Jan 26; 31(2):229-233. PubMed ID: 29252197
    [Abstract] [Full Text] [Related]

  • 6. Blood pressure in children and adolescents with congenital adrenal hyperplasia (21-hydroxylase deficiency): a preliminary report.
    Roche EF, Charmandari E, Dattani MT, Hindmarsh PC.
    Clin Endocrinol (Oxf); 2003 May 26; 58(5):589-96. PubMed ID: 12699440
    [Abstract] [Full Text] [Related]

  • 7. Hypertension in children with congenital adrenal hyperplasia.
    Maccabee-Ryaboy N, Thomas W, Kyllo J, Lteif A, Petryk A, Gonzalez-Bolanos MT, Hindmarsh PC, Sarafoglou K.
    Clin Endocrinol (Oxf); 2016 Oct 26; 85(4):528-34. PubMed ID: 27105393
    [Abstract] [Full Text] [Related]

  • 8. Hydrocortisone suspension and hydrocortisone tablets are not bioequivalent in the treatment of children with congenital adrenal hyperplasia.
    Merke DP, Cho D, Calis KA, Keil MF, Chrousos GP.
    J Clin Endocrinol Metab; 2001 Jan 26; 86(1):441-5. PubMed ID: 11232038
    [Abstract] [Full Text] [Related]

  • 9. Longitudinal analysis of growth and puberty in 21-hydroxylase deficiency patients.
    Van der Kamp HJ, Otten BJ, Buitenweg N, De Muinck Keizer-Schrama SM, Oostdijk W, Jansen M, Delemarre-de Waal HA, Vulsma T, Wit JM.
    Arch Dis Child; 2002 Aug 26; 87(2):139-44. PubMed ID: 12138066
    [Abstract] [Full Text] [Related]

  • 10. Reinstitution of mineralocorticoid therapy in congenital adrenal hyperplasia. Effects on control and growth.
    Jansen M, Wit JM, van den Brande JL.
    Acta Paediatr Scand; 1981 Mar 26; 70(2):229-33. PubMed ID: 7015786
    [Abstract] [Full Text] [Related]

  • 11. Growth of patients with congenital adrenal hyperplasia due to 21-hydroxylase in infancy, glucocorticoid requirement and the role of mineralocorticoid therapy.
    Sellick J, Aldridge S, Thomas M, Cheetham T.
    J Pediatr Endocrinol Metab; 2018 Sep 25; 31(9):1019-1022. PubMed ID: 30173205
    [Abstract] [Full Text] [Related]

  • 12. Congenital Adrenal Hyperplasia in Children: The Relationship between Plasma Renin Activity and Hypertension.
    Lubis SM, Soesanti F, Hidayati EL, Aap BT.
    Iran J Med Sci; 2024 Jun 25; 49(6):377-383. PubMed ID: 38952640
    [Abstract] [Full Text] [Related]

  • 13. Mineralocorticoids in the mechanism of gynecomastia in adrenal hyperplasia caused by 11 beta-hydroxylase deficiency.
    Hochberg Z, Even L, Zadik Z.
    J Pediatr; 1991 Feb 25; 118(2):258-60. PubMed ID: 1993958
    [No Abstract] [Full Text] [Related]

  • 14. [Acute complications during treatment of virilizing congenital adrenal hyperplasia deficiency due to 21-hydroxylase].
    Job JC, Canlorbe P, Lambertz J, Courouble P, Rossier A.
    Ann Pediatr (Paris); 1970 Feb 25; 17(6):426-31. PubMed ID: 5421325
    [No Abstract] [Full Text] [Related]

  • 15. Mineralocorticoid replacement during infancy for salt wasting congenital adrenal hyperplasia due to 21-hydroxylase deficiency.
    Gomes LG, Madureira G, Mendonca BB, Bachega TA.
    Clinics (Sao Paulo); 2013 Feb 25; 68(2):147-52. PubMed ID: 23525308
    [Abstract] [Full Text] [Related]

  • 16. Iatrogenic Cushing's disease in a boy after misdiagnosis of salt-losing virilizing adrenal hyperplasia: impaired metyrapone response with failure of catch-up growth.
    Mendilaharzu H, Gregory T, Gardner LI.
    J Pediatr; 1973 Jul 25; 83(1):69-76. PubMed ID: 4358656
    [No Abstract] [Full Text] [Related]

  • 17. Sodium Chloride Supplementation Is Not Routinely Performed in the Majority of German and Austrian Infants with Classic Salt-Wasting Congenital Adrenal Hyperplasia and Has No Effect on Linear Growth and Hydrocortisone or Fludrocortisone Dose.
    Bonfig W, Roehl F, Riedl S, Brämswig J, Richter-Unruh A, Fricke-Otto S, Hübner A, Bettendorf M, Schönau E, Dörr H, Holl RW, Mohnike K.
    Horm Res Paediatr; 2018 Jul 25; 89(1):7-12. PubMed ID: 29073619
    [Abstract] [Full Text] [Related]

  • 18. Treatment of congenital adrenal hyperplasia in children aged 0-3 years: a retrospective multicenter analysis of salt supplementation, glucocorticoid and mineralocorticoid medication, growth and blood pressure.
    Neumann U, van der Linde A, Krone RE, Krone NP, Güven A, Güran T, Elsedfy H, Poyrazoglu S, Darendeliler F, Bachega TASS, Balsamo A, Hannema SE, Birkebaek N, Vieites A, Thankamony A, Cools M, Milenkovic T, Bonfig W, Costa EC, Atapattu N, de Vries L, Guaragna-Filho G, Korbonits M, Mohnike K, Bryce J, Ahmed SF, Voet B, Blankenstein O, Claahsen-van der Grinten HL.
    Eur J Endocrinol; 2022 Apr 11; 186(5):587-596. PubMed ID: 35290211
    [Abstract] [Full Text] [Related]

  • 19. [Adrenogenital syndrome].
    Fujieda K.
    Nihon Rinsho; 2006 Jun 28; Suppl 2():643-6. PubMed ID: 16817483
    [No Abstract] [Full Text] [Related]

  • 20. Gender dichotomy in long term growth trajectories of children with 21-hydroxylase deficiency congenital adrenal hyperplasia.
    Patel L, Chandrashekhar SR, Gemmell I, O'Shea E, Jones J, Banerjee I, Amin R, Clayton P.
    Horm Res Paediatr; 2011 Jun 28; 75(3):206-12. PubMed ID: 20962509
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.